Trials / Completed
CompletedNCT00932555
EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this international prospective post-marketing surveillance study is to obtain data on treatment procedures, long-term safety and efficacy and patient acceptance of KOGENATE Bayer/FS in treatment of patients with haemophilia A under daily-life treatment conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Recombinant Factor VIII (Kogenate FS, BAY14-2222) | Patients under daily life treatment receiving Kogenate according to local drug information. |
Timeline
- Start date
- 2009-04-01
- Completion
- 2011-12-01
- First posted
- 2009-07-03
- Last updated
- 2012-03-14
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00932555. Inclusion in this directory is not an endorsement.